These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

35 related articles for article (PubMed ID: 6252835)

  • 1. Review of clinical experience with amdinocillin monotherapy and comparative studies.
    Demos CH; Green E
    Am J Med; 1983 Aug; 75(2A):72-81. PubMed ID: 6311009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amdinocillin therapy of experimental animal infections.
    Gordin FM; Sande MA
    Am J Med; 1983 Aug; 75(2A):48-53. PubMed ID: 6311005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carbenicillin plus cefazolin with or without mecillinam as an early treatment of bacteremia caused by gram-negative organisms: randomized double-blind study.
    Klastersky J; Coppens L; Meunier-Carpentier F; Menday AP
    Antimicrob Agents Chemother; 1980 Sep; 18(3):437-42. PubMed ID: 6252835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mecillinam and ampicillin separately or combined in gram-negative septicemia.
    Ekwall E; Scheja A; Cronberg S; Ganrot-Norlin K; Jonsson M; Juhlin I; Kahlmeter G; Thorén A; Thulin KE; Tunevall G
    Infection; 1980; 8(1):37-40. PubMed ID: 6246006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative effectiveness of combinations of amikacin with penicillin G and amikacin with carbenicillin in gram-negative septicemia: double-blind clinical trial.
    Klastersky J; Hensgens C; Meunier-Carpentier F
    J Infect Dis; 1976 Nov; 134 SUPPL():S433-40. PubMed ID: 792359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Significance of antimicrobial synergism for the outcome of gram negative sepsis.
    Klastersky J; Meunier-Carpentier F; Prevost JM
    Am J Med Sci; 1977; 273(2):157-67. PubMed ID: 324279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amdinocillin: use alone or in combination with cefoxitin or carbenicillin-ticarcillin.
    Lawson RD; Estey EH; Bodey GP
    Am J Med; 1983 Aug; 75(2A):113-8. PubMed ID: 6310998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mecillinam (Selexidin) in the treatment of neonates.
    de Louvois J; Mulhall A; Hurley R
    J Perinat Med; 1981; 9(2):87-95. PubMed ID: 6264060
    [No Abstract]   [Full Text] [Related]  

  • 9. Empiric therapy with carbenicillin and gentamicin for febrile patients with cancer and granulocytopenia.
    Schimpff S; Satterlee W; Young VM; Serpick A
    N Engl J Med; 1971 May; 284(19):1061-5. PubMed ID: 4994878
    [No Abstract]   [Full Text] [Related]  

  • 10. Antibacterial activity in serum and urine as a therapeutic guide in bacterial infections.
    Klastersky J; Daneau D; Swings G; Weerts D
    J Infect Dis; 1974 Feb; 129(2):187-93. PubMed ID: 4810941
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical significance of in vitro synergism between antibiotics in gram-negative infections.
    Klastersky J; Cappel R; Daneau D
    Antimicrob Agents Chemother; 1972 Dec; 2(6):470-5. PubMed ID: 4596743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gram-negative infections in cancer. Study of empiric therapy comparing carbenicillin-cephalothin with and without gentamicin.
    Klastersky J; Henri A; Hensgens C; Daneau D
    JAMA; 1974 Jan; 227(1):45-8. PubMed ID: 4202683
    [No Abstract]   [Full Text] [Related]  

  • 13. Empiric therapy for cancer patients: comparative study of ticarcillin-tobramycin, ticarcillin-cephalothin, and cephalothin-tobramycin.
    Klastersky J; Hensgens C; Debusscher L
    Antimicrob Agents Chemother; 1975 May; 7(5):640-5. PubMed ID: 1096809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mecillinam, a novel penicillanic acid derivative with unusual activity against gram-negative bacteria.
    Neu HC
    Antimicrob Agents Chemother; 1976 May; 9(5):793-9. PubMed ID: 949176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ticarcillin in combination with cephalothin or gentamicin as empiric antibiotic therapy in granulocytopenic cancer patients.
    Schimpff SC; Landesman S; Hahn DM; Standiford HC; Fortner CL; Young VM; Wiernik PH
    Antimicrob Agents Chemother; 1976 Nov; 10(5):837-44. PubMed ID: 795372
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.